24 May 2013
Keywords: cortecs, agreement, entered, into, its, second, syndication
Article | 19 December 1994
- Cortecs has entered into its second R&D syndication agreement in
Australia, regarding the development of its Pseudostat and Moniliastat
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 December 1994
12 December 1994
23 May 2013
© 2013 thepharmaletter.com